Joseph Patrick Cooper
CIK: 0001368711
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Quoin Pharmaceuticals, Ltd.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 4, 2026QNRX
Quoin Pharmaceuticals, Ltd.
Award(A)DirectShare Option (Right to Buy)
8.1K shares- - May 29, 2025QNRX
Quoin Pharmaceuticals, Ltd.
Award(A)DirectShare Option (Right to Buy)
7.8K shares- - Dec 9, 2024QNRX
Quoin Pharmaceuticals, Ltd.
Award(A)DirectShare Option (Right to Buy)
50.7K shares-
1-3 of 3 transactions
About Cooper Joseph Patrick
Cooper Joseph Patrick (SEC CIK 0001368711) files insider reports with the SEC as Director of Quoin Pharmaceuticals, Ltd. (QNRX).
Signal8 holds 3 ownership filings by Cooper Joseph Patrick, all Form 4s, filed between Dec 10, 2024 and Feb 6, 2026. Those filings report 3 transactions, from Dec 9, 2024 to Feb 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cooper Joseph Patrick's filings is in ASHBURN, VA.
Recent filings by Cooper Joseph Patrick
Other insiders filing for Quoin Pharmaceuticals, Ltd. (QNRX)
- LANGER DENNIS, Director
- Carter Denise P., Chief Operating Officer
- Myers Michael, Chief Executive Officer
- Lawlor Sally Bridget, Chief Financial Officer
- Culverwell Anthony James, Director
- SEMBER MICHAEL T, Director